Sign in or 

Discussion Spotlight
|
|
| Started By | Thread Subject | Replies | Last Post | ||||
|---|---|---|---|---|---|---|---|
| Rosvik | Understanding numbers and health statistics | 1 | Jun 8 2011, 9:58 AM EDT by lknaapen | ||||
|
Thread started: Oct 4 2010, 5:05 AM EDT
Watch
Regarding the topic discussed in Chicago about understanding numbers I would like to recommend this article "Helping Doctors and Patients Make Sense of Health Statistics" PSYCHOLOGICAL SCIENCE IN THE PUBLIC INTEREST Volume 8—Number 2. 2008 Association for Psychological Science.
Show Last Reply
|
|||||||
| lknaapen | Funding for Patient Involvement Projects (canada) | 0 | Apr 23 2010, 11:31 AM EDT by lknaapen | ||||
|
Thread started: Apr 23 2010, 11:31 AM EDT
Watch
Hi All,
If it is due to a lack of funding that limits your ability to really set up patient involvement projects, here might be the solution! The Canadian Health Services Research Foundation will fund up to 6 projects that involve patients in health care planning etc. Unfortunately I think you have to be a Canadian Permanent resident to apply... Deadline is May 27th, and the project will run from Oct 2010 to Oct 2012. The funding initiative is called "Patient Engagement Projects Initiative", copy and paste the link below for all the info: http://www.chsrf.ca/funding_opportunities/PEPInitiative_Projects_e.php
out of
found this valuable.
Do you find this valuable?
Keyword tags:
funding
|
|||||||
| sylvia_saenger | level of evidence | 0 | Mar 19 2010, 8:15 AM EDT by sylvia_saenger | ||||
|
Thread started: Mar 19 2010, 8:15 AM EDT
Watch
Dear all, I'm looking for a consumer friendly illustration of the level of evidence and grade of recommendations. Has somebody of you experiences with special icons or images? Does it make sense to "translate" the levels of evidence in "consumer friendly icons"?
Thanks for your help and best wishes Sylvia
out of
found this valuable.
Do you find this valuable?
Keyword tags:
level of evidence
|
|||||||
| lknaapen | Consumers role in systematic reviews (and other research) | 0 | Feb 8 2010, 5:26 PM EST by lknaapen | ||||
|
Thread started: Feb 8 2010, 5:26 PM EST
Watch
The Cochrane Consumers Network (CCNet) had an extensive discussion on their mailinglist about the requirements, training, expectations and roles of consumers in the network. Many CCNet members contributed to this discussion over a period of six weeks. Janet Wale prepared a summary of this discussion, included at the bottom of the "resources" page:
http://ginppi.wetpaint.com/page/Links+and+Resources Because of word limit here, i selected a few interesting comments under different headings.. Please see the .pdf file at the page above for the complete summary. Requirements for consumers: Formal education? - Health literacy, keenness to learn, ability to articulate: As a layperson I have trawled the web over several years & have read, learning all the time. One does not require a degree to be knowledgeable, articulate - Be educated to your rights and know your capabilities. Patients depend on truth & transparency. Must have personal experience of the illness, or not? - Consumers can comment and help to improve the review even if they have not experienced the problem themselves. - If that were a requirement, it would be impossible to find consumers to look at every review - I'm a great believer in the healing power of stories, including to convey information, but I don't think they ought to play a role in the actual Cochrane reviews Training, in what? -To respect actual evidence, and have a critical attitude toward medical expertise Essential, or not? - Training will help, but from my experience it would be better to help people to build, improve and be convinced of the capabilities they have, and a thinking mind - Wouldn't it be great if public education around the world offered adequate training in evidence-based health care and how to evaluate the science |
|||||||
| mortabro | Results? | 1 | Nov 30 2009, 10:13 AM EST by lknaapen | ||||
|
Thread started: Nov 30 2009, 8:26 AM EST
Watch
Hello, is there anybody here that have any information or evidences that prove that lay - versions or patient - versions of CPG`s influences in the right way? Do this influence patients and professionals?
Mvh Morten A. Brodahl,collaborator pacient mediated representative for the pasientorganisations in Norways implementationproject - concerning Concurrent Disorder PPIP.
Show Last Reply
|
|||||||
| saskiavanveen | The VU University has made an inventory of patient participation in NL | 0 | Nov 17 2009, 3:40 AM EST by saskiavanveen | ||||
|
Thread started: Nov 17 2009, 3:40 AM EST
Watch
Active patient participation in guideline development is an emerging phenomenon. However, patient participation in guideline development is methodologically still in an early stage of development. Several initiatives are undertaken, but systematic reflections and scientific publications on this topic are limited. To gain more insight in methods and conditions that enhance the effectiveness of patient participation, an exploratory study was conducted on the current practice of patient participation in guideline development particularly in the Netherlands. A literature study took place and semi-structured interviews (n = 46) were conducted among patient representatives, specialists and other parties involved in guideline development. They were identified by studying guideline reports and through the snowball method. The results show that in the Netherlands, patient participation currently takes place in most multidisciplinary guideline development trajectories. The methods mostly used are the inclusion of a patient (representative) in guideline development committees, and consultation of patients through focus groups and/or questionnaires. The results indicate that effectiveness of current initiatives, amongst others, seems to depend on characteristics related to the disease, the level of professionalism of the patient organization, and the attitude of involved professionals. Many conditions have to be fulfilled particularly if patients are to effectively participate in guideline development committees. Among respondents there was no consensus on the most effective form of patient participation in guideline development. It is generally recommended to include patients from the initial phase of guideline development; formulating the key questions is often considered to be the most important stage of involvement. Various recommendations are made; largely based on the Dutch situation. For more information: ppt GIN conference Lissabon
|
|||||||
| aboivin | Industry funding, consumer involvement, and conflicts of interests | 3 | Sep 25 2009, 10:52 AM EDT by lknaapen | ||||
|
Thread started: Mar 5 2009, 7:03 PM EST
Watch
Here are a few questions suggested by Kay Currie from Australia:
"Is there a growth in pharmaceutical companies, governments, and/or industry trying to working through consumer groups to influence guideline recommendations? How can this be identified? What processes can be used to manage? Are current conflict of interest processes adequate to address this?"
out of
found this valuable.
Do you find this valuable?
Keyword tags:
conflict of interest
pharmaceutical industry
Show Last Reply
|
|||||||
| aboivin | What makes a patient representative 'representative'? | 2 | Mar 9 2009, 11:08 AM EDT by lknaapen | ||||
|
Thread started: Dec 16 2008, 12:29 PM EST
Watch
This discussion aims at exploring what people expect from patient representatives and what caracteristics would make them more 'representative'.
Show Last Reply
|
|||||||